Upcoming Policies Effective February 3, 2025

Vasomotor Symptoms - Commercial

Prior Authorization, Quantity Limit

Resmetirom - Medicaid

Prior Authorization, Quantity Limit

Primary Biliary Cholangitis - Medicaid

Prior Authorization, Quantity Limit

Primary Biliary Cholangitis - Commercial

Prior Authorization, Quantity Limit

QP44R1-20 Non-Covered Medicare Services and Organization Determination Reminder for Platinum Blue and Medicare Advantage Subscribers

QP85-24 Update to Cotiviti Hospital Bill Validation (HBV) Services

Medicare 2025 Deductibles Coinsurance Premium overview

Commercial Pharmacy Program Policy Activity Provider Notification

Minnesota Public Employers 2025 Vision Summary of Benefits